Responses
Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
1056 XTX301, a tumor activated, half-life extended IL-12 promoted potent anti-tumor immunity and activity across multiple syngeneic tumor models
Compose a Response to This Article
Other responses
No responses have been published for this article.
